The cancer stem cell (CSC) hypothesis, despite the limitations of the currently available
models and assays, has ushered in a new era of excitement in cancer research. The …

Cancer is a heterogeneous disease, which provides a broad field for investigation, while
simultaneously reducing the chances for a universal treatment. Malignant gliomas are the …

Vasculogenic mimicry (VM) refers to the unique capability of aggressive tumor cells to mimic
the pattern of embryonic vasculogenic networks. In the study we demonstrated that CD133 …

Regeneration of injured tubular cells occurs after acute tubular necrosis primarily from
intrinsic renal cells. This may occur from a pre‐existing intratubular stem/progenitor cell …

Expression of the membrane protein CD133 marks a subset of cancer cells with drug
resistant phenotype and enhanced tumor initiating ability in xenotransplantation assays …

The aim of this study was to evaluate the distribution of inhibin/activin alpha, beta (A) and
beta (B) subunits and follistatin in immature oocytes and in matured oocytes before and after …

Abstract CD133 (prominin-1) is a member of the transmembrane glycoprotein family and
was initially described as a specific marker to select human hematopoietic progenitor cells …

CD133 is a common marker of cancer stem cells (CSCs). We generated an anti-CD3/anti-
CD133 bispecific antibody (BsAb) and bound it to the cytokine-induced killer (CIK) cells as …

Background The aim of this study was to investigate the clinical significances and prognostic
value of CD133 and CD44 (markers of cancer stem‐like cells, CSCs), and vasculogenic …

Prominin-1, a pentaspan transmembrane protein, is a unique cell surface marker commonly
used to identify stem cells, including endothelial progenitor cells and cancer stem cells …